ES530125A0 - Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(i, 2-c)-(i, 3)-benzodiazepinas - Google Patents

Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(i, 2-c)-(i, 3)-benzodiazepinas

Info

Publication number
ES530125A0
ES530125A0 ES530125A ES530125A ES530125A0 ES 530125 A0 ES530125 A0 ES 530125A0 ES 530125 A ES530125 A ES 530125A ES 530125 A ES530125 A ES 530125A ES 530125 A0 ES530125 A0 ES 530125A0
Authority
ES
Spain
Prior art keywords
diazacicloalquilimidazo
benzodiazepinas
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530125A
Other languages
English (en)
Other versions
ES8601189A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8601189A1 publication Critical patent/ES8601189A1/es
Publication of ES530125A0 publication Critical patent/ES530125A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES530125A 1981-12-07 1984-02-28 Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(i, 2-c)-(i, 3)-benzodiazepinas Granted ES530125A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32827481A 1981-12-07 1981-12-07

Publications (2)

Publication Number Publication Date
ES8601189A1 ES8601189A1 (es) 1985-11-01
ES530125A0 true ES530125A0 (es) 1985-11-01

Family

ID=23280276

Family Applications (2)

Application Number Title Priority Date Filing Date
ES517912A Expired ES8501757A1 (es) 1981-12-07 1982-12-03 Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(1,2-c)-(1,3)-benzodiazepinas.
ES530125A Granted ES530125A0 (es) 1981-12-07 1984-02-28 Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(i, 2-c)-(i, 3)-benzodiazepinas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES517912A Expired ES8501757A1 (es) 1981-12-07 1982-12-03 Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(1,2-c)-(1,3)-benzodiazepinas.

Country Status (16)

Country Link
EP (1) EP0081461A3 (es)
JP (1) JPS58109489A (es)
AU (1) AU9131582A (es)
CA (1) CA1180011A (es)
DD (1) DD203547A5 (es)
DK (1) DK540282A (es)
ES (2) ES8501757A1 (es)
FI (1) FI824170L (es)
GB (1) GB2115407B (es)
GR (1) GR77796B (es)
HU (1) HU187191B (es)
IL (1) IL67426A0 (es)
NO (1) NO824090L (es)
NZ (1) NZ202714A (es)
PT (1) PT75940B (es)
ZA (1) ZA828954B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0129509B1 (de) * 1983-06-06 1989-08-23 Ciba-Geigy Ag Triazol(2,3-c)(1,3)benzodiazepine, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
US4595535A (en) * 1983-06-06 1986-06-17 Ciba-Geigy Corporation Diazacycloalkyl-1,2,4-triazolo[2,3-c][1,3]benzodiazepines useful as neuroleptic and/or antihistaminic agents
KR102122470B1 (ko) * 2016-12-08 2020-06-12 주식회사 엘지화학 변성제 및 이로부터 유래된 작용기를 포함하는 변성 공액디엔계 중합체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838122A (en) * 1972-06-30 1974-09-24 J Suh 2-heterocyclic-1,3-benzodiazepines
JPS57118589A (en) * 1980-06-12 1982-07-23 Ciba Geigy Ag Imidazobenzothiazepine, manufacture, pharmaceutical medicine containing same and use as medicine

Also Published As

Publication number Publication date
ES8601189A1 (es) 1985-11-01
ZA828954B (en) 1983-09-28
AU9131582A (en) 1983-06-16
IL67426A0 (en) 1983-05-15
JPS58109489A (ja) 1983-06-29
ES517912A0 (es) 1984-12-01
EP0081461A2 (de) 1983-06-15
DK540282A (da) 1983-06-08
DD203547A5 (de) 1983-10-26
EP0081461A3 (en) 1984-07-18
PT75940B (de) 1985-12-20
PT75940A (de) 1983-01-01
NZ202714A (en) 1986-08-08
CA1180011A (en) 1984-12-27
NO824090L (no) 1983-06-08
ES8501757A1 (es) 1984-12-01
FI824170A0 (fi) 1982-11-03
FI824170L (fi) 1983-06-08
HU187191B (en) 1985-11-28
GB2115407B (en) 1985-07-24
GB2115407A (en) 1983-09-07
GR77796B (es) 1984-09-25

Similar Documents

Publication Publication Date Title
ES543652A0 (es) Procedimiento de obtencion de derivados 1,4-dihidropiridini-cos
ES534539A0 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
ES516841A0 (es) Procedimiento para la obtencion de benzofuranonas
ES537343A0 (es) Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES526892A0 (es) Procedimiento para la obtencion de benzofuranonas
AR227697A1 (es) Procedimiento para la preparacion de 3,4-bis-sustituido 1,2,5,-oxadiazol-2-oxidos
ES500618A0 (es) Procedimiento para la preparacion de 2,3-dicloro-2-trifluo- rometil-1,1,1,3,4,4,5,5,5,-nonafluoropentano
ES528179A0 (es) Procedimiento para la obtencion de 1-fenil-3-azabiciclo(3,1,0)-hexan-2,4-dionas sustituidas
ES543253A0 (es) Procedimiento para la obtencion de isoxazolidinas substitui-das
MX7052E (es) Procedimiento para la preparacion de 2-metoxi-4-amino-5-alquilsulfonil-n-(3-beta-8-azabiciclo-(3,2,1)octil)-benzamidas
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES540173A0 (es) Procedimiento para la obtencion de nuevos 1,3,2-dioxaborina-nos
ES538806A0 (es) Procedimiento para la obtencion de nuevos 1,4-naftoquinonderivados
ES530125A0 (es) Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(i, 2-c)-(i, 3)-benzodiazepinas
AR228166A1 (es) Procedimiento para la fabricacion de derivados de 5,6,7,7a-tetrahidro-4h-tieno(3,2-c)-fenilalquil-5-piridin-2-ona
ES510955A0 (es) Procedimiento para la obtencion de metilomelaminas monomeras
ES505478A0 (es) Procedimiento para la preparacion de 2,5-dimetilhexadieno-2,4
MX155775A (es) Procedimiento mejorado para la preparacion de 2,3,-dicloropropionitrilo
ES529960A0 (es) Procedimiento para la obtencion de alcoximinoalquilamino-1, 3, 5-triazinas
ES523245A0 (es) "procedimiento para la obtencion de carboximetilesteres".
ES511969A0 (es) Procedimiento para la obtencion de 2-aminoetanoles sustituidos.
ES532167A0 (es) Procedimiento para la obtencion de 2, 3-bihidro-2, 2-dimetil-7-benzofuranol
ES508693A0 (es) "procedimiento para la obtencion de derivados de aminoalkilfuranos".
ES505333A0 (es) Procedimiento para la obtencion de 2,4-diclorofenil-imidazol-vinil-cetonas sustituidas
ES535245A0 (es) Procedimiento para la obtencion de disulfuro de 2,2'-dibenzotiazolilo